Subcommittee on Pharmacy and Poisons (Amendment) (No. 5) Regulation 2017

Papers Written submissions and the Administration's response LC Paper No. Paper Meeting date CB(2)240/17-18(01) Administration's response on (a) the policy and the relevant legislation relating to the handling of cases under which a person was in possession of controlled pharmaceutical products with prescriptions by a non-locally registered medical practitioner for personal use; (b) who applied for the registration of Netupitant and its salts, the date of receiving the application, the mechanism and time taken for assessing the application and the date of approving the application; (c) a list of documents required to be produced by an applicant for registration of a pharmaceutical product; and (d) relevant legislation relating to prohibition on Internet sale of controlled pharmaceutical products 31 October 2017